Close

Wells Fargo Maintains an 'Outperform' on Celgene (CELG); Management Meeting Proves Shares Are Attractive

June 18, 2012 10:08 AM EDT Send to a Friend
Wells Fargo maintains an 'Outperform' on Celgene (NASDAQ: CELG) price target range of $82-$86.

Analyst, Brian Abrahams, said, "On ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login